Thorax. Published Online First: 1 February 2008. doi:10.1136/thx.2007.086314
Papers |
The Role Of A Soluble Tnf-Á Receptor Fusion Protein (Etanercept) In Corticosteroid-Refractory Asthma: A Double Blind, Randomised Placebo-Controlled Trial
1 University of Southampton, United Kingdom
2 Queen Alexandra Hospital, Portsmouth, United Kingdom
3 Universita di Catania, Catania, Italy
* To whom correspondence should be addressed. E-mail: jbm{at}soton.ac.uk.
Accepted 19 December 2007
Abstract
Rationale: TNF-
is a cytokine recognized as a therapeutic target in chronic inflammatory diseases.
Objectives and Methods: We report a randomised double-blind placebo-controlled parallel group trial of etanercept (an IgG1-TNF p75 receptor fusion protein), administered once weekly for 12 weeks in 39 patients with symptomatic corticosteroid refractory asthma. Efficacy was measured by change from the pre-treatment baseline in Asthma Related Quality of Life (AQLQ) and Asthma Control (ACQ) Questionnaires scores (the primary end-points), lung function, PEF and bronchial hyperresponsiveness (BHR). We also assessed sputum and serum inflammatory cells and cytokines, serum albumin and C-reactive protein as biomarkers of inflammation.
Main results: There was a small but significant difference in reduction of ACQ scores between treatment and placebo (-1.11 (95%CI -1.56, -0.75) and -0.52 (95%CI -0.97, -0.07) respectively, p=0.030). There was no significant difference in improvements in AQLQ scores between groups (p=0.084), though sub group analyses restricted to 29 patients not taking antidepressants revealed significant improvements in both AQLQ and ACQ. There were no differences in lung function, PEF, BHR or exacerbation rates between groups. Minor adverse events including injection site pain and skin rashes were more frequent with etanercept. There was a significant reduction in sputum macrophages and CRP, and increases in serum TNF-
and albumin following treatment, but not in other laboratory parameters.
Conclusion: ETanercept therapy over 12 weeks demonstrated only a small but significant improvement in asthma control and systemic inflammation as measured by serum albumin and CRP. Larger randomised placebo-controlled trials are required to clarify the role of TNF-
antagonism in subjects with severe refractory asthma.
Keywords: CRP, TNF antagonists, TNF-&[alpha], etanercept, severe asthma
Relevant Articles
-
Antagonism of tumour necrosis factor
in refractory asthma
- Mike A Berry and Ian D Pavord
Thorax 2008 63: 571-572.[Extract] [Full Text] [PDF]
- Airwaves
- Wisia Wedzicha
Thorax 2008 63: 571.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
-
Kang, N.-I., Yoon, H.-Y., Lee, Y.-R., Won, M., Chung, M. J., Park, J.-W., Hur, G. M., Lee, H.-K., Park, B.-H.
(2009). A20 Attenuates Allergic Airway Inflammation in Mice. J. Immunol.
183: 1488-1495
[Abstract] [Full Text] -
Humbert, M.
(2009). Biologics in severe difficult-to-treat asthma: find the right niche!. ERR
18: 51-53
[Full Text] -
Wenzel, S. E., Barnes, P. J., Bleecker, E. R., Bousquet, J., Busse, W., Dahlen, S.-E., Holgate, S. T., Meyers, D. A., Rabe, K. F., Antczak, A., Baker, J., Horvath, I., Mark, Z., Bernstein, D., Kerwin, E., Schlenker-Herceg, R., Lo, K. H., Watt, R., Barnathan, E. S., Chanez, P., on behalf of the T03 Asthma Investigators,
(2009). A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-{alpha} Blockade in Severe Persistent Asthma. Am. J. Respir. Crit. Care Med.
179: 549-558
[Abstract] [Full Text] -
Currie, G. P, Douglas, J G., Heaney, L. G
(2009). Difficult to treat asthma in adults. BMJ
338: b494-b494
[Full Text] -
Berry, M. A, Pavord, I. D
(2008). Antagonism of tumour necrosis factor {alpha} in refractory asthma. Thorax
63: 571-572
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
